These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 28244976

  • 1. The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
    Dubreuil J, Giammarile F, Rousset P, Rubello D, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A.
    Nucl Med Commun; 2017 Apr; 38(4):312-318. PubMed ID: 28244976
    [Abstract] [Full Text] [Related]

  • 2. FDG-PET/ceCT is useful to predict recurrence of Pseudomyxoma peritonei.
    Dubreuil J, Giammarile F, Rousset P, Bakrin N, Passot G, Isaac S, Glehen O, Skanjeti A.
    Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1630-7. PubMed ID: 26907364
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Role of 18F-FDG PET/CT in diagnosing peritoneal carcinomatosis in the restaging of patient with ovarian cancer as compared to contrast enhanced CT and tumor marker Ca-125.
    Rubini G, Altini C, Notaristefano A, Merenda N, Rubini D, Ianora AA, Asabella AN.
    Rev Esp Med Nucl Imagen Mol; 2014 Aug; 33(1):22-7. PubMed ID: 23948509
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of a modified peritoneal cancer index using FDG-PET/CT (PET-PCI) in predicting tumor grade and progression-free survival in patients with pseudomyxoma peritonei.
    Hotta M, Minamimoto R, Gohda Y, Igari T, Yano H.
    Eur Radiol; 2019 Oct; 29(10):5709-5716. PubMed ID: 30874878
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Diagnostic value of contrast-enhanced CT combined with 18-FDG PET in patients selected for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Sommariva A, Evangelista L, Pintacuda G, Cervino AR, Ramondo G, Rossi CR.
    Abdom Radiol (NY); 2018 May; 43(5):1094-1100. PubMed ID: 28770289
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The maximum standardized uptake value and extent of peritoneal involvement may predict the prognosis of patients with recurrent ovarian cancer after primary treatment: A retrospective clinical study.
    Jiang Y, Hou G, Wu F, Zhu Z, Zhang W, Cheng W.
    Medicine (Baltimore); 2020 Feb; 99(8):e19228. PubMed ID: 32080121
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prognostic Importance of Bone Marrow Uptake on Baseline 18F-FDG Positron Emission Tomography in Diffuse Large B Cell Lymphoma.
    Soydal C, Koksoy EB, Yasar A, Turgal E, Erdogan BD, Akbulut H, Kucuk NO.
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Early prediction of response to chemotherapy and survival in malignant pleural mesothelioma using a novel semiautomated 3-dimensional volume-based analysis of serial 18F-FDG PET scans.
    Francis RJ, Byrne MJ, van der Schaaf AA, Boucek JA, Nowak AK, Phillips M, Price R, Patrikeos AP, Musk AW, Millward MJ.
    J Nucl Med; 2007 Sep; 48(9):1449-58. PubMed ID: 17704250
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of F-18 FDG PET/CECT vs. CECT for detecting recurrence of periampullary carcinoma and its prognostic significance.
    Santhosh S, Mittal BR, Kang M, Kapoor R, Gupta R, Rana S, Bhattacharya A, Bhasin D.
    Abdom Imaging; 2015 Jun; 40(5):1131-7. PubMed ID: 25655637
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response.
    Liberale G, Lecocq C, Garcia C, Muylle K, Covas A, Deleporte A, Hendlisz A, Bouazza F, El Nakadi I, Flamen P.
    Anticancer Res; 2017 Feb; 37(2):929-934. PubMed ID: 28179354
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.